Cargando…
Safety assessment of a novel C-type natriuretic peptide derivative and the mechanism of bone- and cartilage-specific toxicity
ASB20123, a C-type natriuretic peptide/ghrelin chimeric peptide, was designed as a novel peptide and demonstrated full agonistic activity for natriuretic-peptide receptor B and a significantly longer half-life in plasma compared with the native peptide. We researched the toxicological profile of ASB...
Autores principales: | Yotsumoto, Takafumi, Morozumi, Naomi, Nakamura, Ryuichi, Jindo, Toshimasa, Furuya, Mayumi, Abe, Yasuyuki, Nishimura, Tomonari, Maeda, Hiroaki, Ogasawara, Hiroyuki, Minamitake, Yoshiharu, Kangawa, Kenji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6738601/ https://www.ncbi.nlm.nih.gov/pubmed/31509532 http://dx.doi.org/10.1371/journal.pone.0218229 |
Ejemplares similares
-
ASB20123: A novel C-type natriuretic peptide derivative for treatment of growth failure and dwarfism
por: Morozumi, Naomi, et al.
Publicado: (2019) -
Foramen magnum stenosis and midface hypoplasia in C-type natriuretic peptide-deficient rats and restoration by the administration of human C-type natriuretic peptide with 53 amino acids
por: Yotsumoto, Takafumi, et al.
Publicado: (2019) -
Exogenous C-type natriuretic peptide restores normal growth and prevents early growth plate closure in its deficient rats
por: Hirota, Keisho, et al.
Publicado: (2018) -
Rats deficient C-type natriuretic peptide suffer from impaired skeletal growth without early death
por: Fujii, Toshihito, et al.
Publicado: (2018) -
A novel physiological significance of natriuretic peptides in cancer metastasis
por: Kangawa, Kenji, et al.
Publicado: (2013)